B-type natriuretic peptide assessment in the diagnosis of rejection after pediatric heart transplant;Evaluación del péptido natriurético tipo B en el diagnóstico de rechazo tras transplante cardiaco pediátrico

Arquivos Brasileiros de Cardiologia

Volumn 92, Issue 3, 2009, Pages 221-226

  De Sylos, Cristina ^a,b   Azeka, Estela ^a   Kajita, Luis ^a   Benvenutti, Luis ^a   Strunz, Célia Cassaro ^a   Branco, Klébia Castello ^a   Riso, Arlindo Almeida ^a   Tanamati, Carla ^a   Jatene, Marcelo ^a   Barbero Marcial, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

B type; Biopsy; Children; Graft rejection; Heart transplantation; Natriuretic peptide

Indexed keywords

AZATHIOPRINE; BRAIN NATRIURETIC PEPTIDE; CALCINEURIN INHIBITOR; CORTICOSTEROID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART HEMODYNAMICS; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MALE; PATIENT ASSESSMENT; PRESCHOOL CHILD; SCHOOL CHILD; BIOPSY; BLOOD; GRAFT REJECTION; HEART MUSCLE; NONPARAMETRIC TEST; PATHOLOGY;

ADOLESCENT; BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 65949086147     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2009000300011     Document Type: Article

References (35)

1. Azeka E, Barbero-Marcial M, Jatene M, Auler JO, Ramires JA. Eight years experience of pediatric heart transplantation: clinical outcome using noninvasive methods for the evaluation of acute rejection. Pediatr Transplant. 2002; 6 (3): 208-213
2. Azeka E, Ramires JA, Valler C, Bocchi E. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. J Am Coll Cardiol. 2002; 40 (11): 2034-2038
3. Boucek MM, Aurora P, Edwards LB, Taylor DO, Trulock EP, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report - 2007. J Heart Lung Transplant. 2007; 26 (8): 796-807.
4. Azeka E, Barbero Marcial M, Soares J, Camargo PR, Jatene M, Auler JO, et al. The importance of noninvasive methods on the evaluation of acute rejection in pediatric transplantation: Gallium 67 scintigraphy as an option. In: 2nd World Congress Pediatric Cardiology and Cardiac Surgery, Honolulu, 1998. Proceedings. Honolulu; 1998. p. 133-136
5. Azeka E. Transplante cardíaco em crianças - análise clínica evolutiva. [Tese]. São Paulo: Faculdade de Medicina da Universidade de São Paulo; 1998.
6. Zales VR, Crawford S, Backer CL, Pahl E, Webb CL, Lynch P, et al. Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children. J Am Coll Cardiol. 1999; 23 (3): 766-771
7. Wagner K, Oliver MC, Boyle GJ, Miller SA, Law YM, Pigula F, et al. Endomyocardial biopsy in pediatric heart transplant recipients; a useful exercise? (Analysis of 1169 biopsies). Pediatr Transplant. 2000; 4 (3): 186-192
8. Siaplaouras J, Thul J, Kramer U, Bauer J, Schranz D. Cardiac troponin I: a marker of acute heart rejection in infant and child heart recipients. Pediatr Transplant. 2003; 7 (1): 43-45
9. Arnau-Vives MA, Almenar L, Hervas I, Osa A, Martinez-Dolz L, Rueda J, et al. Preditive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant. 2004; 23 (7): 850-856 (Pubitemid 38953868)
10. Park MH, Uber PA, Scott RL, Mehra MR. B-type natriuretic peptide in heart transplantation: an important marker of allograft performance. Heart Fail Rev. 2003, 8 (4): 359-363
11. Abramson LP, Pahl E, Huang L, Stellmach V, Rodgers S, Mavroudis C, et al. Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation. Transplantation. 2002; 73 (1): 153-156 (Pubitemid 34094705)
12. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, et al. Plasma brain natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol. 2004; 43 (3): 416-422
13. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. Bnatriuretic peptide and ischemia in patients with stable coronary disease. Circulation. 2003; 108 (24): 2987-2992
14. Mayer SA, De Lemos JA, Murphy SA, Brooks S, Robert BJ, Grayburn PA. Comparison of B-natriuretic peptide levels in patients with heart failure versus without mitral regurgitation. Am J Cardiol. 2004; 15 (8): 1002-1006
15. Kruger S, Graf J, Kumz D, Stickel T, Hanrath P, Jansens U. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol. 2002; 21 (4): 718-722
16. Tang WH, Girod JP, Lee MJ, Starling RC, Ypung JB, Van Lente F, et al. Plasma brain natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation. 2003; 208 (24): 2964-2966 (Pubitemid 37553562)
17. Wang TJ, Larson MG, Levy D, Benjamin E, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350 (7): 655-663 (Pubitemid 38364624)
18. Groenning B, Raymond I, Hildebrandt PR, Nilsson JC, Baumann M, Pedersen F. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by Plasma N terminal pro-Brain natriuretic peptide concentration in a large sample of general population. Heart. 2004; 90 (3): 297-303.
19. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990; 9: 587-593
20. Schiller NB, Shaw PK, Crawford M, De Maria A, Devereux R, Feigenbaun H. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardography Committee on Standars. Subcommittee on quantitation of two dimensional echocardiograms. J Am Soc Echocardiogr. 1989; 2: 358-367
21. Bickel PJ, Doksum KA. Mathematical statistics: basic ideas and select topics. San Francisco: Holden Day; 1997. p. 153-191
22. Costa Neto PLO. Estatística. São Paulo: Ed Edgard Blucher; 1977. p. 78.
23. Shou M, Gustafsson F, Nielsem PH, Madsen LH, Kjaer A, Hildebrandt R. Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure during steady state. Eur J Heart Fail. 2007; 9: 68-74.
24. Shaw S, Williams SG. Is brain natriuretic peptide clinically useful after cardiac transplantation. J Heart Lung Transplant. 2005; 12: 1396-1401
25. Mehra MR, Uber WE, Walther D, Vesely M, Wohlgemuth JG, Prentice J, et al. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker. Circulation. 2006; 4: 21-26
26. Lan YT, Chang RK, Alejos JC, Burch C, Wetzel GT. B-type natriuretic peptide in children after cardiac transplantation. J Heart Lung Transplant. 2004; 23 (5): 558-563
27. Hervas I, Almenar L, Perez-Pastor JL, Chirivella M, Osa A, Martinez-Doltz P, et al. Radioimmunometric assay of B-type natriuretic peptide (BNP) in heart transplantation: correlation between BNP determination and biopsy grading of rejection. Nucl Med Commun. 2003; 24 (8): 925-931
28. Ationu A, Sorensen K, Whitehead B, Singer D, Burch M, Carter ND. Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children - a three year follow up. Cardiovasc Res. 1993; 27 (12): 2135-2139
29. Ilene Claudius MD, Yueh-Tze Lan MD, Chang RK, Wetzel GT, Alejos J. Usefulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients. Am J Cardiol. 2003; 92 (11): 1368-1370
30. O'Neill JO, Mcrae AT, Troughton RW, Kenneth NG, Taylor DO, Yamani MH, et al. Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients. J Heart Lung Transplant. 2005; 24 (4): 416-420 (Pubitemid 40403797)
31. Hammerer-Lercher A, Mair J, Antretter H, Ruttmann E, Poeltzl G, Laufer G, et al. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation. J Heart Lung Transplant. 2005; 24 (9): 1444-1447 (Pubitemid 41247835)
32. Akioka K, Takeuchi K, Yanagi S, Hirota K, Sakamoto K, Yoshimura T, et al. Prognostic value of Doppler transmitral flow patterns and cardiac natriuretic peptides in patients with chronic congestive heart failure admitted for episodes of acute descompensation. Heart Vessels. 2000; 15 (2): 53-60. (Pubitemid 32042347)
33. Mehra MR, Uber WE, Park MH, Scott RL. Anything but a biopsy: monitoring for cardiac allograft rejection. Curr Opin Cardiol. 2002; 17: 131-136
34. Wagner K, Oliver MC, Boyle GJ, Miller SA, Law YM, Pigula F, et al. Endomyocardial biopsy in pediatric heart transplantation: a useful exercise (analysis of 1169 biopsies). Pediatric Transplant. 2000; 4: 186-192
35. Stehlik J, Starling RC, Movsesian MA, Fang JC, Brown RN, Hess MI, et al. Utility of long term surveillance endomyocardial biopsy: a multi-institutional analysis. J Heart Lung Transplant. 2006; 25: 1402-1409